Literature DB >> 312818

Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages.

E Handman, A W Burgess.   

Abstract

The intracellular protozoan parasite Leishmania tropica was found to survive unharmed and to multiply for several days in normal mouse peritoneal macrophages. In contrast, when infected monolayers were treated with GM-CSF, there was a continuous decrease in the percentage of infected cells, reaching less than 10% on day 4 in culture, compared to about 30% in normal controls. Microscopic observations showed an increased number of dead parasites in GM-CSF treated infected cells. Within 5 hr of incubation with GM-CSF, almost 40% of intracellular parasites showed morphologic damage, compared to less than 10% in untreated cells. Pretreatment of macrophage monolayers with pure GM-CSF before infection led to an increased level of phagocytosis of L. tropica parasites as reflected by the percentage of infected cells and the increased number of parasites in each infected cell. GM-CSF treated cultures showed 73% infected cells containing a mean of five parasites per cell, as compared to controls in which only about 50% of macrophages were infected with only two parasites per cell. The number of dead parasites per cell was 5-fold higher in the GM-CSF treated cultures at 2 hr. After 24 hr the percentage of infected GM-CSF treated cells was less than one-third that in the control cultures.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312818

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Anti-bacterial activity of peritoneal cells from transgenic mice producing high levels of GM-CSF.

Authors:  H T Tran; D Metcalf; C Cheers
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

2.  Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.

Authors:  X Cao; W Zhang; J Wang; M Zhang; X Huang; H Hamada; W Chen
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

3.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense.

Authors:  M Oka; H Nagasawa; Y Ito; K Himeno
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 5.  A (selective) history of Australian involvement in cytokine biology.

Authors:  Nicos A Nicola
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

6.  Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.

Authors:  D K Blanchard; M B Michelini-Norris; C A Pearson; S McMillen; J Y Djeu
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

7.  Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei.

Authors:  T Yokokura; K Nomoto; T Shimizu; K Nomoto
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 8.  Effector cells, molecules and mechanisms in host-protective immunity to parasites.

Authors:  G F Mitchell
Journal:  Immunology       Date:  1979-10       Impact factor: 7.397

9.  Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.

Authors:  R G Titus; A Kelso; J A Louis
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

10.  Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice.

Authors:  Carole Dumas; Anthony Muyombwe; Gaétan Roy; Claudine Matte; Marc Ouellette; Martin Olivier; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.